Trial Outcomes & Findings for Perfusion Imaging and CT -Understanding Relative Efficacy (NCT NCT00486447)

Results Overview

Number of subjects with CT for detection purposes

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

249 participants

Primary outcome timeframe

through study completion, an expected average of 1 year

Results posted on

2017-08-23

Participant milestones
Measure	Imaging Enrolled subjects for general imaging
Overall Study STARTED	249
Overall Study COMPLETED	249
Overall Study NOT COMPLETED	0

Withdrawal data not reported

Gender was not record for analysis for this study.

Baseline characteristics by cohort
Measure	Imaging n=249 Participants General imaging subjects receiving CT exams 64 Channel VCT: cardiac CT angiography exam
Age, Continuous	30 years n=249 Participants
Sex: Female, Male Female	0 Participants Gender was not record for analysis for this study.
Sex: Female, Male Male	0 Participants Gender was not record for analysis for this study.

Timeframe: through study completion, an expected average of 1 year

Population: Data were not collected for analysis.

Number of subjects with CT for detection purposes

Outcome measures
Measure	Enrolled Enrolled subjects for general imaging
Detection of Significant Coronary Artery Disease Using Diagnostic Catheterization for Standard of Truth.	0

Timeframe: 1 year outcomes after initial MPS exam

Population: Data were not collected for analysis.

Outcome measures
Measure	Enrolled Enrolled subjects for general imaging
Clinical Outcomes - EKG, Laboratory Workup, Changes in Medical Management, Downstream Cardiac Testing, Significant Coronary Interventions, and Major Cardiac Events & Long-term Outcomes (Non-fatal MI and Cardiac-related Death).	0

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

GE Healthcare

Phone: 262-226-9495